Irene Wessel

Medicin og biovidenskab

1. Head and Neck Neoplasms 100%
2. Squamous Cell Carcinoma 34%
3. Electrochemotherapy 34%
4. Type II DNA Topoisomerase 31%
5. Neoplasms 30%
6. Squamous Cell Carcinoma of Head and Neck 28%
7. Mouth 28%
8. Deglutition Disorders 27%
9. Quality of Life 27%
10. Salivary Glands 24%
11. Adenoid Cystic Carcinoma 24%
12. Mouth Neoplasms 24%
13. Dexrazoxane 23%
14. Neck 22%
15. Deglutition 22%
16. Survival 21%
17. Topoisomerase II Inhibitors 21%
18. Rehabilitation 19%
19. Head 19%
20. Radiotherapy 18%
21. Systematic Reviews 16%
22. Small Cell Lung Carcinoma 15%
23. Mutation 15%
24. Population 13%
25. Denmark 13%
26. Therapeutics 12%
27. Sublingual Gland 12%
28. Mouth Rehabilitation 12%
29. Etoposide 12%
30. Cancer Survivors 12%
31. MicroRNAs 12%
32. Enhanced Recovery After Surgery 11%
33. Oropharyngeal Neoplasms 11%
34. Pleomorphic Adenoma 11%
35. Gene Fusion 11%
36. Laryngectomy 10%
37. Adenosine Triphosphate 10%
38. Enzymes 10%
39. Retrospective Studies 9%
40. Randomized Controlled Trials 9%
41. Comorbidity 9%
42. Biopsy 9%
43. Robotics 9%
44. Electroporation 8%
45. Recurrence 7%
46. Razoxane 7%
47. Multimodal Imaging 7%
48. Refeeding Syndrome 7%
49. Lymphoma 7%
50. Voice Quality 7%